Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - Mediclinic International plc

27th Jul 2022 09:09

RNS Number : 9132T
Societe Generale SA
27 July 2022
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Société Générale S.A.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mediclinic International plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

26/07/2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

Ordinary

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

8,253,036

1.12

21,192

0.00

(2) Cash-settled derivatives:

 

0

0.00

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.00

0

0.00

 

TOTAL:

8,253,036

1.12

21,192

0.00

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit GBP

Ordinary

Purchase

600

4.784

Ordinary

Purchase

371

4.772

Ordinary

Purchase

2,619

4.754

Ordinary

Purchase

868

4.784

Ordinary

Purchase

500

4.81

Ordinary

Purchase

188

4.81

Ordinary

Purchase

32

4.756

Ordinary

Purchase

136

4.774

Ordinary

Purchase

511

4.774

Ordinary

Purchase

845

4.806

Ordinary

Purchase

1,161

4.814

Ordinary

Purchase

147

4.772

Ordinary

Sale

70

4.802

Ordinary

Sale

103

4.802

Ordinary

Sale

308

4.802

Ordinary

Sale

119

4.788

Ordinary

Sale

360

4.788

Ordinary

Sale

13

4.788

Ordinary

Sale

161

4.83

Ordinary

Sale

124

4.83

Ordinary

Sale

373

4.83

Ordinary

Sale

600

4.804

Ordinary

Sale

98

4.798

Ordinary

Sale

600

4.798

Ordinary

Sale

600

4.788

Ordinary

Sale

206

4.816

Ordinary

Sale

467

4.816

Ordinary

Sale

672

4.81

Ordinary

Sale

600

4.804

Ordinary

Sale

98

4.81

Ordinary

Sale

406

4.81

Ordinary

Sale

167

4.81

Ordinary

Sale

670

4.816

Ordinary

Sale

195

4.814

Ordinary

Sale

124

4.814

Ordinary

Sale

181

4.814

Ordinary

Sale

600

4.798

Ordinary

Sale

171

4.814

Ordinary

Sale

669

4.818

Ordinary

Sale

127

4.808

Ordinary

Sale

600

4.786

Ordinary

Sale

600

4.81

Ordinary

Sale

146

4.83

Ordinary

Sale

180

4.83

Ordinary

Sale

304

4.83

Ordinary

Sale

600

4.782

Ordinary

Sale

159

4.782

Ordinary

Sale

155

4.786

Ordinary

Sale

149

4.792

Ordinary

Sale

136

4.804

Ordinary

Sale

85

4.804

Ordinary

Sale

373

4.802

Ordinary

Sale

224

4.79

Ordinary

Sale

164

4.802

Ordinary

Sale

107

4.822

Ordinary

Sale

190

4.802

Ordinary

Sale

135

4.822

Ordinary

Sale

131

4.822

Ordinary

Sale

178

4.784

Ordinary

Sale

244

4.804

Ordinary

Sale

112

4.804

Ordinary

Sale

84

4.806

Ordinary

Sale

90

4.814

Ordinary

Sale

87

4.804

Ordinary

Sale

155

4.788

Ordinary

Sale

81

4.804

Ordinary

Sale

153

4.804

Ordinary

Sale

335

4.822

Ordinary

Sale

220

4.784

Ordinary

Sale

393

4.776

Ordinary

Sale

70

4.788

Ordinary

Sale

272

4.806

Ordinary

Sale

144

4.796

Ordinary

Sale

130

4.796

Ordinary

Sale

100

4.772

Ordinary

Sale

143

4.796

Ordinary

Sale

111

4.776

Ordinary

Sale

118

4.802

Ordinary

Sale

193

4.772

Ordinary

Sale

293

4.796

Ordinary

Sale

431

4.8

Ordinary

Sale

386

4.776

Ordinary

Sale

130

4.79

Ordinary

Sale

118

4.79

Ordinary

Sale

74

4.79

Ordinary

Sale

91

4.814

Ordinary

Sale

201

4.772

Ordinary

Sale

90

4.814

Ordinary

Sale

151

4.79

Ordinary

Sale

151

4.79

Ordinary

Sale

102

4.772

Ordinary

Sale

142

4.784

Ordinary

Sale

153

4.784

Ordinary

Sale

137

4.826

Ordinary

Sale

159

4.76

Ordinary

Sale

162

4.786

Ordinary

Sale

115

4.814

Ordinary

Sale

122

4.818

Ordinary

Sale

120

4.818

Ordinary

Sale

107

4.802

Ordinary

Sale

125

4.798

 

Total Purchases

7,978

 

 

Total Sales

20,293

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit GBP

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

GBP

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit GBP

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable) GBP

 

 

 

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

27/07/2022

Contact name:

Paul Jenkins

Telephone number*:

+44 20 7676 6969

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETPPUAUMUPPURM

Related Shares:

MDC.L
FTSE 100 Latest
Value8,328.60
Change52.94